Subcommittee F04.42 on Biomaterials and Biomolecules for TEMPs


    Showing results 1-19 of 19 matching ACTIVE standards under the jurisdiction of F04.42     F04 Home

    F2027-16 Standard Guide for Characterization and Testing of Raw or Starting Materials for Tissue-Engineered Medical Products

    F2064-17 Standard Guide for Characterization and Testing of Alginates as Starting Materials Intended for Use in Biomedical and Tissue Engineered Medical Product Applications

    F2103-18 Standard Guide for Characterization and Testing of Chitosan Salts as Starting Materials Intended for Use in Biomedical and Tissue-Engineered Medical Product Applications

    F2131-02(2012) Standard Test Method for In Vitro Biological Activity of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) Using the W-20 Mouse Stromal Cell Line

        See also WK67352 proposed revision

    F2150-19 Standard Guide for Characterization and Testing of Biomaterial Scaffolds Used in Regenerative Medicine and Tissue-Engineered Medical Products

    F2212-19 Standard Guide for Characterization of Type I Collagen as Starting Material for Surgical Implants and Substrates for Tissue Engineered Medical Products (TEMPs)

        See also WK68915 proposed revision

        See also WK70847 proposed revision

    F2259-10(2012)e1 Standard Test Method for Determining the Chemical Composition and Sequence in Alginate by Proton Nuclear Magnetic Resonance (1H NMR) Spectroscopy

    F2260-18 Standard Test Method for Determining Degree of Deacetylation in Chitosan Salts by Proton Nuclear Magnetic Resonance (1H NMR) Spectroscopy

    F2347-15 Standard Guide for Characterization and Testing of Hyaluronan as Starting Materials Intended for Use in Biomedical and Tissue Engineered Medical Product Applications

    F2450-18 Standard Guide for Assessing Microstructure of Polymeric Scaffolds for Use in Tissue-Engineered Medical Products

    F2602-18 Standard Test Method for Determining the Molar Mass of Chitosan and Chitosan Salts by Size Exclusion Chromatography with Multi-angle Light Scattering Detection (SEC-MALS)

    F2603-06(2012) Standard Guide for Interpreting Images of Polymeric Tissue Scaffolds

    F2605-16 Standard Test Method for Determining the Molar Mass of Sodium Alginate by Size Exclusion Chromatography with Multi-angle Light Scattering Detection (SEC-MALS)

    F2791-15 Standard Guide for Assessment of Surface Texture of Non-Porous Biomaterials in Two Dimensions

    F2952-14 Standard Guide for Determining the Mean Darcy Permeability Coefficient for a Porous Tissue Scaffold

    F3089-14 Standard Guide for Characterization and Standardization of Polymerizable Collagen-Based Products and Associated Collagen-Cell Interactions

    F3142-16 Standard Guide for Evaluation of in vitro Release of Biomolecules from Biomaterials Scaffolds for TEMPs

    F3259-17 Standard Guide for Micro-computed Tomography of Tissue Engineered Scaffolds

    F3354-19 Standard Guide for Evaluating Extracellular Matrix Decellularization Processes

    Showing results 1-5 of 5 matching Proposed New Standards under the jurisdiction of F04.42     F04 Home

    WK51697 Testing and Characterization of Alginate Foam Scaffolds Used in Tissue Engineered Medical Products (TEMPs)

    WK65476 Characterizing Fiber-Based Constructs for Tissue Engineered Medical Products

    WK64460 Pre-clinical Testing Considerations for Materials Used to Regerate Muscle

    WK72274 Printability of Bioinks for Extrusion-based Bioprinting

    WK73220 Standard Guide for Characterization and Testing of Mammalian Fibrinogen as Starting Materials Intended for Use in Biomedical and Tissue Engineered Medical Product Applications

    Showing Results 1-2 of 2 matching WITHDRAWN standards under the jurisdiction of F04.42     F04 Home

    F2883-11 Standard Guide for Characterization of Ceramic and Mineral Based Scaffolds used for Tissue-Engineered Medical Products (TEMPs) and as Device for Surgical Implant Applications (Withdrawn 2020)

    F2900-11 Standard Guide for Characterization of Hydrogels used in Regenerative Medicine (Withdrawn 2020)